Dr. Rajamannar Thennati (DIN: 001415412) retires from the Board of Directors of Sun Pharma Advanced Research Company Limited upon completion of his term as a Director.
The retirement is effective at the ensuing 21st Annual General Meeting scheduled for August 10, 2026.
Appointment of Managing Director & CEO
Mr. Anil Raghavan (DIN: 03548731) has been appointed as Managing Director and Chief Executive Officer of the Company.
The appointment is effective from August 11, 2026, immediately following the AGM.
Mr. Raghavan will be liable to retire by rotation.
The appointment is subject to the approval of members at the ensuing 21st Annual General Meeting of the Company.
Director Profile and Background
Mr. Anil Raghavan currently serves as the Chief Executive Officer of Sun Pharma Advanced Research Company Limited (SPARC).
He is responsible for developing and executing strategies to realize SPARC's vision of becoming a Global Pharmaceutical Leader with a portfolio of innovative solutions.
He operates from SPARC's Mumbai office.
Mr. Raghavan also serves as a mentor of an early stage Machine Learning company, AIRAMATRIX Private Limited, which focuses on the application of high content image processing and deep learning to transform drug development and clinical practice.
He spent a decade consulting with leading firms such as Arthur Andersen, KPMG and Cambridge.
Compliance and Eligibility
Mr. Anil Raghavan is not related to any other director of the Company.
He is not debarred from holding the office of director by any SEBI order or any other authority.
Disclosure Context
Additional details are provided as per SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024.
The disclosure was filed on July 13, 2026, by Kajal Damania, Company Secretary and Compliance Officer.
